Skip to main content
Explore URMC

menu

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)

Research Question:
Does the drug UTR1147A help patients with ulcerative colitis?

Basic Study Information

Purpose:
This study is designed to evaluate the efficacy, safety, and pharmacokinetics of UTTR1147A compared with vedolizumab and with placebo in the treatment of participants with moderate to severe UC. This study will consist of two parts, Part A and Part B. Part A will test the induction of clinical remission and Part B will test the durability of clinical remission.

Location: University of Rochester Medical Center

Study Contact Information

Study Coordinator: Reference Study ID: GA39925 www.roche.com/about_roche/roche_worldwide.htm
Phone: (888) 662-6728
Email: global-roche-genentech-trials@gene.com

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search